maralixibat

maralixibat Mirum Pharmaceuticals Initiates Rolling Submission of a New Drug Application for Maralixibat for the Treatment of Cholestatic Pruritus in […]

Read more

FDA Approves Qdolo

FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain ATHENS, Ga., Sept. 8, 2020 /PRNewswire/ — […]